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Autographa californica nuclear polyhedrosis virus (AcMNPV) pp31 is a nuclear phosphoprotein that accu-
mulates in the virogenic stroma, which is the viral replication center in the infected-cell nucleus, binds to DNA,
and serves as a late expression factor. Considering that reversible phosphorylation could influence its func-
tional properties, we examined phosphorylation and dephosphorylation of pp31 in detail. Our results showed
that pp31 is posttranslationally phosphorylated by both cellular and virus-encoded or -induced kinases.
Threonine phosphorylation of pp31 by the virus-specific kinase activity was sensitive to aphidicolin, indicating
that it requires late viral gene expression. We also found that pp31 is dephosphorylated by a virus-encoded or
-induced phosphatase(s), indicating that phosphorylation of pp31 is a dynamic process. Analysis of pp31 fusion
proteins showed that pp31 contains at least three phosphorylation sites. The amino-terminal 100 amino acids
of pp31 include at least one serine residue that is phosphorylated by a cellular kinase(s). The C-terminal 67
amino acids of pp31 include at least one threonine residue that is phosphorylated by the virus-specific
kinase(s). Finally, this C-terminal domain of pp31 includes at least one serine that is phosphorylated by either
a host or viral kinase(s). Interestingly, site-directed mutagenesis of the consensus threonine phosphorylation
sites in the C-terminal domain of pp31 failed to prevent threonine phosphorylation, suggesting that the
virus-specific kinase is unique and has an undetermined recognition site.
Reversible phosphorylation is an important posttransla-
tional modification that can modulate the functions of many
cellular enzymes and transcription factors, control protein syn-
thesis and macromolecular assembly, and regulate cell cycle
progression and signal transduction pathways (reviewed in ref-
erences 4, 8, 13, and 14). The activities of many viral proteins
also can be regulated by phosphorylation, and this can be an
important factor in viral replication (reviewed in references 21
and 31).
The baculoviruses are rod-shaped, double-stranded DNA
viruses that infect arthropods (reviewed in reference 1). One of
the best-characterized baculoviruses, Autographa californica
nuclear polyhedrosis virus (AcMNPV), encodes several differ-
ent phosphoproteins (7, 11, 25, 29, 41, 42), as well as its own
kinase (32) and phosphatase (19, 35), which suggests that re-
versible phosphorylation is an important control mechanism in
AcMNPV replication. This idea is supported by the results of
studies on the protamine-like AcMNPV protein p6.9 (45) and
its homolog in Plodia interpunctella granulosis virus, VP12 (9).
Both p6.9 and VP12 are dephosphorylated prior to condensa-
tion and packaging of viral DNA, and the dephosphorylated
forms of these proteins have a greater affinity for DNA and are
the only forms found in mature budded virions. Consequently,
it is believed that dephosphorylation of p6.9 and VP12 is nec-
essary for viral DNA condensation and packaging and that
rephosphorylation by a capsid-associated kinase decondenses
and releases the viral DNA from nucleocapsids for a new
round of replication (43, 44). The finding that dephosphory-
lated p6.9 is degraded in cells treated with cytochalasin D,
which inhibits nucleocapsid morphogenesis, is consistent with
the proposed role of p6.9 in viral DNA packaging and nucleo-
capsid assembly (29). Another AcMNPV protein that appears
to be regulated by phosphorylation is the transcription factor,
IE1 (12). The phosphorylation pattern of IE1 is modified when
it is bound to enhancer DNA, suggesting that DNA binding
alters the structure of IE1 and the accessibility of one or more
of its phosphorylation sites (7).
The product of the AcMNPV 39K gene, pp31, is a phospho-
protein that accumulates in the virogenic stroma and binds to
DNA in a non-sequence-specific fashion (11). pp31 has three
basic regions (BRs) that function interdependently as nuclear
and virogenic stroma localization signals and one BR that is
essential for DNA binding (5). The accumulation of pp31 in
the virogenic stroma, which is the viral replication center
within infected-cell nuclei, and its DNA-binding activity sug-
gest that this phosphoprotein plays an important role in viral
replication. pp31 also has been identified as a late-gene expres-
sion factor that might function in stabilization of late tran-
scripts or as part of the transcription complex (23, 38). Since
phosphorylation can regulate many of the properties attributed
to pp31, including nuclear localization, DNA binding, and
transcription factor activity, we have examined phosphoryla-
tion and dephosphorylation of pp31 in more detail.
MATERIALS AND METHODS
Cells and viruses. The methods and conditions used for cell culture have been
described previously (30, 37). Sf9 cells are a subclone of IPLB-Sf21-AE (40) and
were maintained in TNM-FH medium supplemented with 10% (vol/vol) heat-
inactivated fetal bovine serum (JRH Biosciences, Lenexa, Kans.), 1.25 mg of
amphotericin B (Sigma Chemical Co., St. Louis, Mo.) per ml, 25 mg of genta-
micin (Sigma) per ml, and 0.1% (wt/vol) pluronic F68 (BASF Corp., Parsippany,
N.J.) (28). Radiolabeling medium was methionine- or phosphate-free Grace’s
medium supplemented with 0.5% (vol/vol) heat-inactivated fetal bovine serum.
The E2 strain of wild-type AcMNPV and the recombinant baculoviruses used in
this study have been described previously (5, 24, 36), and the paper by Broussard
et al. (5) includes a detailed description of the methods used to construct the
recombinant viruses encoding pp31–b-glucuronidase (pp31-GUS) fusion pro-
teins. Briefly, these recombinants encode all or part of the wild-type pp31 protein
fused to the Escherichia coli GUS protein, pp31-GUS fusion proteins with mu-
tations in the pp31 BRs, or nonfused GUS, and expression of each of these
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proteins is controlled by the polyhedrin promoter. The pp31-GUS fusion pro-
teins, the consensus phosphorylation sites and BRs in pp31, and the C-terminal
region of pp31 are shown diagramatically in Fig. 1. All baculoviruses used in this
study were propagated and their titers were determined by plaque assay in Sf9
cells, as described previously (30, 37).
Metabolic labeling and biochemical fractionation. Sf9 cells were infected at a
multiplicity of infection of 5 PFU per cell and labeled at various times postin-
fection with 100 mCi of [35S]Translabel (about 80% [35S]methionine and 20%
[35S]cysteine; ICN Radiochemicals, Irvine, Calif.) per ml or 200 mCi of 32Pi
(ICN) per ml. For some experiments, Sf9 cells were infected, incubated, and
radiolabeled (18 to 24 h postinfection) in the presence of 5 mg of aphidicolin per
ml. Cytosolic and nuclear fractions were prepared by the detergent-free frac-
tionation method of Jarvis et al. (15), except that NaOH was omitted from the
sample extraction buffer and equivalent samples of cytosolic and nuclear frac-
tions were analyzed without acetone precipitation of the cytosolic fraction. Un-
less otherwise indicated, phosphatase inhibitors (0.2 mM sodium orthovanadate,
30 mM sodium PPi, 50 mM NaF, and 1 mM EDTA) were included in all buffers
used during subcellular fractionations, extractions, and immunoprecipitations.
Samples of each fraction were immunoprecipitated with rabbit polyclonal anti-
pp31 (11, 16), separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) (20), and subjected to phosphoamino acid compositional
analysis as described below.
pp31 was transiently expressed in Sf9 cells by calcium phosphate-mediated
cotransfection with pBD11 (5; renamed p39K in this paper) and pAcIE1 (12) as
described previously (30, 37). The transfected cells were labeled from 24 to 28 h
posttransfection, separated into nuclear and cytosolic fractions, immunoprecipi-
tated with anti-pp31, and separated by SDS-PAGE, as described above.
Phosphoamino acid compositional analysis. Phosphoamino acid analysis was
performed by a modification of the procedure described by Kamps (17). At 24 h
postinfection, 32Pi-labeled cells were washed from tissue culture dishes, pelleted,
and divided into nuclear and cytosolic fractions, as described above, or resus-
pended directly in immunoprecipitation wash buffer (50 mM Tris-HCl [pH 8.0],
100 mM NaCl, 0.1% Nonidet P-40, 0.1% SDS, 1% sodium deoxycholate, 500
kallikrein-inactivating units of aprotinin per ml). Extracts were triturated
through a 27-gauge needle to shear genomic DNA, immunoprecipitated with
anti-pp31, and separated by SDS-PAGE. The precipitated proteins were trans-
ferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore Corp.,
Bedford, Mass.) (39), and the membranes were rinsed three times with water,
dried, and exposed to film. The radiolabeled proteins of interest were excised
from the membrane, and the membrane slices were rewetted with methanol. The
membrane pieces were then submerged in 6 N HCl, flushed with N2, and
hydrolyzed at 1108C for 2 h. The membrane slices were subsequently removed,
and the hydrolysates were dried in a Speed Vac model A160 concentrator
(Savant Instruments, Inc., Farmingdale, N.Y.) and resuspended in pH 1.9 buffer
(glacial acetic acid, formic acid, water [4:1:45, vol/vol/vol], 0.3 mM EDTA). The
hydrolysates were mixed with phosphoamino acid standards, spotted onto cellu-
lose thin-layer chromatography plates, and separated by electrophoresis in the
first dimension in pH 1.9 buffer and in the second dimension in pH 3.5 buffer
(glacial acetic acid, pyridine, water [10:1:89, vol/vol/vol], 0.3 mM EDTA). Phos-
phoamino acid standards were visualized by spraying the plates with a 0.25%
(wt/vol) solution of ninhydrin in acetone, incubating them at 428C for 15 min;
they were then dried and exposed to film.
RESULTS
Time course of pp31 synthesis and phosphorylation. A pre-
vious study had shown that pp31 is phosphorylated, accumu-
lates in the virogenic stroma, and binds to double-stranded
DNA (11). However, no further information was available on
the timing of pp31 phosphorylation during infection or on the
nature of the kinases that modify pp31. To begin to address
these questions, we examined the time course of pp31 synthesis
and phosphorylation during AcMNPV infection. Sf9 cells were
infected with wild-type AcMNPV, pulse-labeled with either
[35S]Translabel or 32Pi at different times postinfection, sepa-
rated into nuclear and cytosolic fractions, and immunoprecipi-
tated with rabbit polyclonal anti-pp31. SDS-PAGE analysis of
the immunoprecipitates showed that pp31 was synthesized and
phosphorylated throughout infection (Fig. 2A). However,
phosphorylation of pp31 appeared to lag slightly behind syn-
thesis, because labeling with 35S was first detected at 0 to 4 h
postinfection whereas labeling with 32Pi was first detected at 4
to 8 h postinfection. Previously, it had been reported that
32Pi-labeled pp31 was detected only in the nuclear fraction (11,
18), but we clearly detected phosphorylated pp31 in both the
cytosolic and nuclear fractions in this study (Fig. 2B). This
apparent discrepancy can be explained by the fact that phos-
phatase inhibitors were included in the extraction buffers in
this but not in the previous studies. Several proteins coprecipi-
tated with nuclear pp31 at later times of infection, and at least
one of these was heavily phosphorylated. None of these pro-
FIG. 1. Structures of pp31 and pp31-GUS fusion proteins. The thin line represents pp31, the hatched box represents GUS, and the shaded boxes represent BR 1
through BR4. In the drawing at the top of the figure, the consensus kinase recognition sites in pp31 are identified by the letter P. In the drawing at the bottom of the
figure, the kinase recognition sites within the C-terminal region of pp31 are bracketed, the predicted serine and threonine phosphorylation sites are circled, BR3 and
BR4 are boxed, and the mutation (dlBR4) used to delete the consensus threonine phosphorylation sites in the C-terminal region of pp31 is shown underneath. WT,
wild type.
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teins was recognized by anti-pp31 in immunoblots (data not
shown), and their identity is unknown.
Phosphoamino acid analysis of the pp31 immunoprecipi-
tated from AcMNPV infected-cell lysates showed that it con-
tained both phosphoserine and phosphothreonine but no de-
tectable phosphotyrosine (Fig. 3).
Differential phosphorylation of pp31 in infected and unin-
fected cells. Transient-expression assays were used to compare
pp31 phosphorylation in uninfected and infected Sf9 cells.
Pulse-labeling, radioimmunoprecipitation, and SDS-PAGE
analysis showed that pp31 could be labeled with 32Pi in unin-
fected Sf9 cells (Fig. 4A). The proportion of both newly syn-
thesized and phosphorylated pp31 in the cytosolic fraction
appeared to be slightly higher in uninfected than in infected
cells, but these results were not quantitated. Phosphoamino
acid analysis showed that pp31 from uninfected cells contained
only phosphoserine (Fig. 4B) whereas pp31 from infected cells
contained both phosphoserine and phosphothreonine (Fig.
4B), as before (Fig. 3). It is difficult to see the phosphothreo-
nine spot in the cytosolic pp31 sample from infected cells in
Fig. 4B, but we know that this subpopulation contains phos-
phothreonine, because it was seen very clearly in other exper-
iments (Fig. 5 and data not shown). The radiolabeling results
shown in Fig. 2B and 4A clearly indicated that pp31 is phos-
FIG. 2. Time course of pp31 biosynthesis and phosphorylation. AcMNPV- or
mock-infected Sf9 cells were metabolically labeled at the indicated times postin-
fection and separated into nuclear (N) and cytosolic (C) fractions. The fractions
were immunoprecipitated with anti-pp31, the immunoprecipitates were sepa-
rated by SDS-PAGE (12% acrylamide), and the gels were dried and exposed to
film. In both panels, the numbers on the left indicate the molecular sizes (in
kilodaltons) of protein standards and the arrow on the right marks the position
of pp31. (A) Cells labeled with [35S]Translabel. (B) Cells labeled with 32Pi.
FIG. 3. Phosphoamino acid composition of pp31. AcMNPV-infected Sf9
cells were labeled with 200 mCi of 32Pi per ml from 18 to 24 h postinfection, and
pp31 was immunoprecipitated from total-cell lysates, resolved by SDS-PAGE
(12% acrylamide), transferred to polyvinylidene difluoride membranes, and hy-
drolyzed as described in Materials and Methods. The hydrolysate was mixed with
phosphoamino acid standards, spotted onto a cellulose thin-layer chromatogra-
phy plate, and separated by high-voltage electrophoresis in two dimensions, as
indicated by the arrows. The phosphoamino acid standards were visualized by
staining with ninhydrin, and the plate was dried and exposed to film. The
positions of the phosphotyrosine (pTyr), phosphoserine (pSer), and phospho-
threonine (pThr) standards are circled and labeled. The positions of free phos-
phate and partial-hydrolysis products are indicated by Pi and peptides, respec-
tively.
FIG. 4. Differential phosphorylation of pp31 in infected and uninfected cells.
Sf9 cells were transfected with AcMNPV DNA (AcNPV), a plasmid encoding
pp31 (p39K), or salmon sperm DNA (s.s.) and labeled with [35S]Translabel or
32Pi from 20 to 24 h posttransfection. The cells were fractionated, and pp31 was
immunoprecipitated from the nuclear (N, Nuc) and cytosolic (C, Cyto) fractions
and used for SDS-PAGE and phosphoamino acid compositional analysis as
described in the legend to Fig. 3. (A) SDS-PAGE analysis (12% acrylamide). The
numbers on the left indicate the molecular sizes (in kilodaltons) of protein
standards. The location of the pp31 bands is indicated on the right. (B) Phos-
phoamino acid analysis of the pp31 bands from panel A.
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phorylated in both infected and uninfected Sf9 cells, suggesting
that it must be phosphorylated by a cellular kinase(s). Further-
more, the difference in the phosphoamino acid compositions of
pp31 from uninfected and infected cells suggests that pp31 is
additionally phosphorylated by a virus-encoded or -induced
kinase.
Since progression from the early to the late phase of AcM
NPV infection can be blocked by inhibiting DNA synthesis, we
examined the phosphoamino acid compositions of pp31 ex-
pressed in the presence or absence of aphidicolin. The results
showed that pp31 produced in aphidicolin-treated cells lacked
phosphothreonine, which indicates that this modification of
pp31 requires late viral gene expression (Fig. 5). It is not clear
from these data, however, whether the late viral gene prod-
uct(s) influences threonine phosphorylation of pp31 directly or
indirectly.
Dephosphorylation of pp31 in infected and uninfected cells.
AcMNPV encodes a protein tyrosine/serine-threonine phos-
phatase (19, 35), and it was of interest to determine whether
pp31 is a target for this phosphatase activity. AcMNPV-in-
fected Sf9 cells were labeled with 32Pi, divided into cytosolic
and nuclear fractions, and immunoprecipitated in the presence
or absence of phosphatase inhibitors. In the absence of phos-
phatase inhibitors, phosphorylated pp31 was detected only in
the nuclear fraction (Fig. 6A), as reported previously (11, 18).
By contrast, 32Pi-labeled pp31 was seen in both fractions when
the cells were fractionated and immunoprecipitated in the
presence of phosphatase inhibitors (Fig. 6A). Phosphoamino
acid analyses of pp31 showed that pp31 isolated in the absence
of phosphatase inhibitors contained only phosphoserine
whereas pp31 prepared in the presence of inhibitors contained
both phosphoserine and phosphothreonine (Fig. 6B). These
results indicated that phosphorylated amino acids in cytosolic
pp31 and phosphorylated threonines in nuclear pp31 are sen-
sitive to dephosphorylation by a phosphatase activity in AcM
NPV-infected cells.
Analysis of 32Pi-labeled pp31 expressed in uninfected cells
showed that phosphorylated pp31 could be detected in both
the cytosolic and nuclear fractions, irrespective of the addition
of phosphatase inhibitors (Fig. 6C). pp31 isolated from unin-
fected cells always contained phosphoserine but never con-
tained phosphothreonine or phosphotyrosine (Fig. 4B and data
not shown). These data suggest that the phosphothreonine(s)
on pp31 is reversibly phosphorylated by virus-encoded or -in-
duced kinase and phosphatase activity(ies).
Phosphorylated domains in pp31. pp31 was analyzed with
the Motifs subroutine of the University of Wisconsin Genetics
Computer Group package (10). Thirteen consensus kinase rec-
ognition sites were identified, most of which were clustered
around BR1 to BR4 in pp31 (Fig. 1). To begin to map the
phosphorylation sites in pp31, we examined the phosphoamino
acid compositions of several pp31-GUS fusion proteins (5). Sf9
cells were infected with recombinant baculoviruses encoding
fusion proteins composed of the amino-terminal 100 or 207
amino acids of pp31 fused to GUS, the C-terminal 67 amino
acids (208 to 275) of pp31 fused to GUS, or the full-length
pp31 protein fused to GUS (shown diagramatically in Fig. 1).
A recombinant baculovirus that expresses nonfused GUS was
used as a negative control.
When expressed in infected cells, the four fusion proteins
were labeled with 32Pi but nonfused GUS was not (Fig. 7A),
indicating that each fusion protein contained phosphorylation
sites derived from pp31. Phosphoamino acid analysis showed
that the full-length pp31-GUS fusion, like wild-type pp31, con-
tained both phosphoserine and phosphothreonine (Fig. 7F).
The fusion protein containing only the C-terminal 67 amino
acids of pp31 also contained both phosphoserine and phospho-
threonine (Fig. 7E). However, the fusion proteins containing
the first 100 or 207 amino acids of pp31 contained only phos-
phoserine (Fig. 7C and D). These results suggest that the
infected cell-specific threonine phosphorylation site in pp31 is
located within its C-terminal 67 amino acids. These results also
suggest that the N-terminal 100 amino acids and C-terminal 67
amino acids of pp31 each contain at least one serine phosphor-
ylation site.
The computer analysis of potential kinase recognition sites
within pp31 had identified four putative threonine-containing
phosphorylation sites at Thr-120, Thr-150, Thr-252, and Thr-
256 (Fig. 1). From this analysis, we predicted that Thr-252
and/or Thr-256 might be the residue(s) phosphorylated by the
virus-encoded or -induced kinase during AcMNPV infection.
We tested this hypothesis by analyzing the phosphoamino acid
compositions of various pp31-GUS fusion proteins containing
mutations in BR4. BR4 overlaps the consensus kinase recog-
nition sites for Thr-252 and Thr-256, and the mutations in BR4
eliminate both of these sites. Interestingly, 208–275pp31/
GUSDBR4 still contained both phosphoserine and phospho-
threonine (Fig. 8G). This result suggests that the virus-
encoded or -induced kinase which phosphorylates the
threonine(s) within the C-terminal 67 amino acids of pp31 is
a novel kinase with a unique recognition site.
Analysis of additional pp31-GUS fusion proteins with BR
mutations that altered consensus serine phosphorylation sites
showed that 1–100pp31/GUSDBR1, 1–207pp31/GUSDBR1,
1–207pp31/GUSDBR2, and 1–207pp31/GUSDBR1/2 all con-
tained phosphoserine (Fig. 8A to E). Thus, these mutations
were unable to conclusively reveal whether any of these sites
are used for phosphorylation of pp31.
DISCUSSION
The known properties of the AcMNPV pp31 protein, includ-
ing its localization in the nucleus and virogenic stroma, its
non-sequence-specific DNA-binding activity, and its capability
to stimulate the expression of late genes, suggest that it plays
an important role in AcMNPV replication (5, 11, 38). Further-
FIG. 5. Influence of late viral gene expression on phosphorylation of pp31.
Sf9 cells were infected with AcMNPV and radiolabeled with 200 mCi of 32Pi per
ml from 18 to 24 h postinfection in the presence (1) or absence (2) of aphidi-
colin. pp31 was isolated from the cytosolic (Cyto) and nuclear (Nuc) fractions
and used for phosphoamino acid analyses as described in the legend to Fig. 3.
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more, pp31 is a phosphoprotein, and since phosphorylation
can influence any or all of these properties, it is reasonable to
expect that the function of pp31 might be regulated by revers-
ible phosphorylation. To begin to address this possibility, we
have examined phosphorylation and dephosphorylation of
pp31 in detail.
A time course analysis showed that pp31 is phosphorylated
throughout AcMNPV infection, but pp31 synthesis was detect-
able before phosphorylation, which is consistent with the ex-
pectation that phosphorylation is a posttranslational event.
The detection of pp31 phosphorylation at early times (4 to 8 h)
after infection indicated that it must be modified by a cellular
and/or early viral kinase(s). A role for a host cell kinase(s) in
the phosphorylation of pp31 was supported by the demonstra-
tion that pp31 can be phosphorylated in uninfected Sf9 cells.
Also, there was a striking difference in the phosphoamino acid
compositions of pp31 produced in uninfected and infected
cells. While pp31 from uninfected cells contained only phos-
phoserine, pp31 from infected cells contained both phospho-
serine and phosphothreonine. Thus, pp31 must be additionally
modified by a virus-encoded or -induced kinase during AcM-
NPV infection. No phosphotyrosine was detected in pp31 ex-
pressed under any conditions, which is consistent with the
results of previous studies showing that other baculovirus pro-
teins contained only phosphoserine and phosphothreonine,
not phosphotyrosine (18, 25, 26, 29).
Protein kinase activity has been detected in occluded and
budded virions of AcMNPV (26) and in nucleocapsids of Plo-
dia interpunctella granulosis virus (43), and kinase activity is
induced in cells infected with Bombyx mori nuclear polyhedro-
sis virus (46). A putative serine/threonine protein kinase gene,
pk1, has been identified in AcMNPV (32) and in Lymantria
dispar nuclear polyhedrosis virus (3). The AcMNPV pk1 gene
is classified as late or very late, and both viral pk1 genes encode
proteins with in vitro kinase activity. AcMNPV also has a
truncated protein kinase gene, pk2, which is classified as an
early gene (22). Thus, there is substantial evidence that bacu-
loviruses encode their own protein kinases. Since threonine
phosphorylation of pp31 was detected only in infected cells and
was sensitive to aphidicolin, which blocks late-gene expression,
it is reasonable to conclude that threonine phosphorylation of
pp31 is probably carried out by AcMNPV PK1, which is a
late-gene product. It also is possible that AcMNPV PK2 is
involved in serine phosphorylation of pp31 early in infection,
FIG. 6. Dephosphorylation of pp31 in infected and uninfected cells. Sf9 cells were infected with AcMNPV or transfected with a plasmid encoding pp31 and
radiolabeled with 32Pi. The labeled cells were then separated into nuclear (N, Nuc) and cytosolic (C, Cyto) fractions, and the fractions were immunoprecipitated with
anti-pp31 in the presence (1) or absence (2) of phosphatase (P’tase) inhibitors. pp31 was isolated from each fraction and used for phosphoamino acid analyses, as
described in the legend to Fig. 3. (A) SDS-PAGE analysis of pp31 from infected cells. (B) Phosphoamino acid analysis of pp31 bands from panel A. (C) SDS-PAGE
analysis of pp31 isolated from transfected cells.
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but this seems less likely, because PK2 lacks several motifs
found in eucaryotic kinases and probably has no kinase activity
(22). Definitive tests of these preliminary conclusions will re-
quire analysis of the phosphoamino acid composition of pp31
expressed by AcMNPV mutants lacking functional pk1 and pk2
genes.
AcMNPV also encodes a protein tyrosine/serine-threonine
phosphatase (19, 35). Since the phosphothreonine in pp31 is
sensitive to dephosphorylation in AcMNPV-infected but not
uninfected Sf9 cells, it is reasonable to conclude that the phos-
phothreonine in pp31 can be dephosphorylated by the virus-
encoded protein tyrosine/serine-threonine phosphatase. A
subpopulation of the phosphoserines in pp31 also was sensitive
to dephosphorylation by a virus-encoded or -induced phos-
FIG. 7. Mapping phosphorylated domains in pp31. Sf9 cells were infected with wild-type (WT) AcMNPV or recombinant baculoviruses encoding part or all of the
pp31 protein fused to GUS. pp31 or pp31-GUS fusion proteins were immunoprecipitated from infected-cell lysates and used for SDS-PAGE and phosphoamino acid
analyses as described in the legend to Fig. 3. (A) SDS-PAGE analysis (10% acrylamide). The antisera used for immunoprecipitation and the viruses used for infection
are indicated at the top, the numbers on the left indicate the molecular sizes (in kilodaltons) of protein standards, and the locations of pp31, the pp31-GUS fusion
proteins, and GUS are indicated on the right. (B to F) Phosphoamino acid compositions of pp31 (B), 1–100pp31/GUS (C), 1–207pp31/GUS (D), 208–275pp31/GUS
(E), and 1–275pp31/GUS (F).
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phatase, because the cytosolic fraction of pp31 from infected
cells lacked detectable phosphoserine. Overall, these results
lead us to conclude that phosphorylation of pp31 is a dynamic
process that is governed, at least in part, by a virus-encoded or
-induced kinase(s) and phosphatase(s). However, the func-
tional significance of these reversible phosphorylation events,
if any, is unclear.
To begin to map the phosphorylation sites in pp31, we ex-
pressed various pp31-GUS fusion proteins in recombinant bac-
ulovirus-infected Sf9 cells, determined whether they could be
labeled with 32Pi, and examined their phosphoamino acid com-
positions. Fusion proteins containing amino acids 1 to 100, 1 to
207, or 208 to 275 of pp31 could be labeled with 32Pi. The
fusion proteins containing amino acids 1 to 100 or 1 to 207 of
pp31 contained only phosphoserine, and the former fusion
protein also could be 32Pi labeled in uninfected Sf9 cells (data
not shown). By contrast, fusion proteins containing full-length
pp31 or amino acids 208 to 275 of pp31 contained both phos-
phoserine and phosphothreonine. Together, these results indi-
cated that pp31 is phosphorylated on at least three sites.
Amino acids 1 to 100 and 208 to 275 of pp31 each include at
least one serine phosphorylation site that can be phosphory-
lated by a cellular kinase. Amino acids 208 to 275 also includes
a threonine phosphorylation site that can be phosphorylated by
a virus-encoded or -induced kinase. Interestingly, mutations
within the two consensus threonine kinase recognition sites
within amino acids 208 to 275 failed to prevent threonine
phosphorylation. This suggests that one or more of the six
additional threonines in this region of pp31 must lie within an
undefined recognition site that can be phosphorylated by the
virus-encoded or -induced kinase, perhaps PK1. Mutagenesis
of additional threonine residues in this region of pp31 should
allow us to identify the virus-specific phosphorylation site(s).
From the results of this study, we propose a working model
to describe how phosphorylation might influence the activity of
pp31. This model states that pp31 is initially synthesized as an
unphosphorylated precursor (pp310), which is posttranslation-
ally phosphorylated by a cellular kinase(s) that recognizes at
least one serine phosphorylation site within amino acids 1 to
100 and produces a partially phosphorylated intermediate,
pp311. During the late stage of AcMNPV replication, pp311 is
additionally phosphorylated by PK1, which recognizes at least
one threonine residue in a novel recognition site within amino
acids 208 to 275 of pp31 and produces pp312. Phosphorylation
of a threonine(s) and some serines in pp31 is dynamic, subject
to reversal by the action of the AcMNPV protein tyrosine/
serine-threonine phosphatase. At some point, cellular and/or
viral kinases must phosphorylate at least one additional serine
located within amino acids 208 to 275 of pp31.
Previous studies have demonstrated that reversible phos-
phorylation can modulate the functions of proteins with key
roles in viral replication and gene expression. For example, the
rate of nuclear localization (33) and the DNA-binding speci-
ficity (6, 31, 34) of simian virus 40 large T antigen are regulated
by phosphorylation. Phosphorylation of the phosphoprotein
(p) subunit of the vesicular stomatitis virus RNA polymerase
by both cellular and viral kinases is required for transcriptional
activation (2). Although this study did not reveal what influ-
ence, if any, phosphorylation and dephosphorylation might
have on any of the known properties of pp31, it seems likely
that these modifications will have functional significance, and
future studies will be designed to test this working hypothesis.
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